FIELD: medicine.
SUBSTANCE: group of inventions refers to medicine, namely to otolaryngology, and may be used for treating tinnitus in a person in need thereof. That is ensured by introducing a therapeutically effective dose of a 1-aminoalkylcyclohexane derivative specified in neramexane or its pharmaceutically acceptable salt. The therapeutically effective dose of neramexane is introduced daily for a first period making at least three months and followed by a second period making at least one month. The second period involves introducing neramexane in a dose making 0-75% of the therapeutically effective dose provided when neramexane is not introduced during the second period, the treatment of the first period is repeated after the second period.
EFFECT: group of inventions provides clinical effectiveness in treating and preventing tinnitus, as well as a need of maintenance therapy.
24 cl, 1 dwg, 8 tbl, 3 ex
